Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution
- PMID: 39747812
- PMCID: PMC11697218
- DOI: 10.1038/s41467-024-55325-4
Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution
Abstract
Single-cell RNA sequencing (scRNA-seq) has advanced our understanding of cell types and their heterogeneity within the human liver, but the spatial organization at single-cell resolution has not yet been described. Here we apply multiplexed error robust fluorescent in situ hybridization (MERFISH) to map the zonal distribution of hepatocytes, spatially resolve subsets of macrophage and mesenchymal populations, and investigate the relationship between hepatocyte ploidy and gene expression within the healthy human liver. Integrating spatial information from MERFISH with the more complete transcriptome produced by single-nucleus RNA sequencing (snRNA-seq), also reveals zonally enriched receptor-ligand interactions. Finally, MERFISH and snRNA-seq analysis of fibrotic liver samples identify two hepatocyte populations that expand with injury and do not have clear zonal distributions. Together these spatial maps of the healthy and fibrotic liver provide a deeper understanding of the cellular and spatial remodeling that drives disease which, in turn, could provide new avenues for intervention and further study.
© 2024. The Author(s).
Conflict of interest statement
Competing interests: R.J.X. is a co-founder of Celsius Therapeutics and Jnana Therapeutics, board director at MoonLake Immunotherapeutics, and consultant to Nestlé. J.R.M is a co-founder of, stake-holder in, and advisor for Vizgen. J.R.M. is an inventor on patents associated with MERFISH applied for on his behalf by Harvard University and Boston Children’s Hospital. J.R.M.‘s interests were reviewed and are managed by Boston Children’s Hospital in accordance with their conflict-of-interest policies. J.R.M. has received research funding from Merck for unrelated projects. A.C.M. has received research funding from Boehringer Ingelheim and GlaxoSmithKline for unrelated projects. The remaining authors declare no competing interests.
Figures






References
-
- Teutsch, H. F. The modular microarchitecture of human liver. Hepatology42, 317–325 (2005). - PubMed
-
- Gebhardt, R. Metabolic zonation of the liver: Regulation and implications for liver function. Pharm. Therapeut53, 275–354 (1992). - PubMed
-
- Jungermann, K. & Keitzmann, T. Zonation of Parenchymal and Nonparenchymal Metabolism in Liver. Annu Rev. Nutr.16, 179–203 (1996). - PubMed
-
- Martini, T., Naef, F. & Tchorz, J. S. Spatiotemporal Metabolic Liver Zonation and Consequences on Pathophysiology. Annu. Rev. Pathol.: Mech. Dis.18, 439–466 (2023). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical